Skip to main content

Immunovant, Inc.

IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001764013

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

Q2 2024 vs. Q1 2024

How the institutions holding Immunovant, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of IMVT: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders2092197−10
Shares70.4M70.1K74.8M+4.43M (+6.3%)
Value$2.27B$2.26M$1.97B−$297.2M (−13.1%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Immunovant, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to IMVT in Q2 2024
InstitutionSharesValue% of portfolio
T. Rowe Price Investment Management, Inc.1,625,220$42.9M0.03%
Canada Pension Plan Investment Board199,800$5.27M0.01%
Alps Advisors Inc113,931$3.01M0.02%
Rubric Capital Management LP58,624$1.55M0.04%
Tejara Capital Ltd55,210$1.46M0.53%
Mirae Asset Global ETFs Holdings Ltd.32,956$867.9K0.00%
Corebridge Financial, Inc.31,228$824.4K0.00%
Schonfeld Strategic Advisors LLC22,227$586.8K0.00%
Winton Group Ltd20,675$545.8K0.04%
Exchange Traded Concepts, LLC17,684$466.9K0.01%
Gsa Capital Partners LLP14,824$391.0K0.03%
Engineers Gate Manager LP13,564$358.1K0.01%
Aigen Investment Management, LP13,323$351.7K0.07%
Scientech Research LLC12,634$333.5K0.07%
Farallon Capital Management, L.L.C.12,000$316.8K0.00%
Harbour Capital Advisors, LLC9,400$258.6K0.06%
Headlands Technologies LLC2,927$77.3K0.01%
Twin Tree Management, LP2,201$58.1K0.00%
Catalyst Funds Management Pty Ltd2,200$58.1K0.02%
BFSG, LLC600$15.8K0.00%
Ronald Blue Trust, Inc.155$5.01K0.00%
Smartleaf Asset Management LLC113$2.94K0.00%
Innealta Capital, LLC59$1.56K0.00%
CIBC Private Wealth Group, LLC17$4700.00%
Allworth Financial LP7$1960.00%

Sold out (35)

Institutions that held Immunovant, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (2)

Institutions that held Immunovant, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMVT in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG68,119$2.20M
Cutler Group LP2,000$64.0K